Press Releases

Date Title and Summary
Toggle Summary Accuray to Report Third Quarter Fiscal 2023 Financial Results on April 26, 2023
SUNNYVALE, Calif. , April 13, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2023, ended March 31, 2023 , during a conference call hosted by company management at 1:30 p.m. PT / 4:30 p.m. ET on April 26, 2023 .
Toggle Summary Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare Conference
Company to Take Part in Fireside Chat Tuesday, March 14, 2023 at 1:00pm PST / 4:00pm EST SUNNYVALE, Calif. , March 8, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 33 rd  Annual Oppenheimer Healthcare Conference taking place March 13-15, 2023.
Toggle Summary Accuray to Participate in the Cowen 43rd Annual Health Care Conference
Company to Take Part in Fireside Chat Monday , March 6, 2023 at 10:30am PST / 1:30pm EST SUNNYVALE, Calif. , Feb. 21, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 43 rd Annual Health Care Conference taking place March 6-8, 2022 .
Toggle Summary Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves Urinary Continence and Sexual Function Better Than Surgery in Men With Prostate Cancer
SUNNYVALE, Calif. , Feb. 16, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from the randomized, multicenter trial PACE-A (PACE - Prostate Advances in Comparative Evidence) indicates that stereotactic body radiation therapy (SBRT), in comparison to surgery,
Toggle Summary Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
SUNNYVALE, Calif. , Feb. 7, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the virtual BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference , which takes place February 14-16, 2023 .     BTIG-hosted events are intended for
Toggle Summary Accuray Reports Fiscal 2023 Second Quarter Financial Results
Delivered strong Q2 performance amidst challenging macroenvironment; Reiterate fiscal year guidance     SUNNYVALE, Calif. , Feb. 1, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter of fiscal 2023 ended December 31, 2022 .
Toggle Summary Robert C. Kill Joins Accuray Board of Directors
SUNNYVALE, Calif. , Feb. 1, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Robert C. Kill to the company's Board of Directors, effective as of January 30, 2023 . Mr. Kill is a skilled healthcare executive with more than 30 years' experience transforming
Toggle Summary European Radiosurgery Center Munich Invests in Second Accuray CyberKnife® System to Support the Demand for High-Precision Radiosurgery Treatments
Center believes the CyberKnife System is the #1 tool for delivery of advanced radiosurgery treatments Selected the latest generation CyberKnife S7™ System to increase the number of indications they can treat throughout the body, and the patients they can help SUNNYVALE, Calif. , Jan.
Toggle Summary Accuray to Report Second Quarter Fiscal 2023 Financial Results on February 1, 2023
SUNNYVALE, Calif., Jan. 18, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2023, ended December 31, 2022, after the market close on February 1, 2023. Management will host a conference call to review the results at 1:30
Toggle Summary Accuray Announces First Patient Treatments in New Zealand With the CyberKnife® System, the World's Only Robotic Radiation Therapy Delivery Device
Auckland Radiation Oncology Selected the Latest-Generation CyberKnife S7™ System to Deliver Precise Treatments More Quickly, so Patients Can Rapidly Return to the Activities They Enjoy SUNNYVALE, Calif. , Jan. 17, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.